IP Library Granted Patent US 7,912,540
Granted Patent B2
US 7,912,540 · App. 11/424,141 · Granted Mar 22, 2011

Article of clothing for treating a tumor or the like

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,912,540
App. No.
11/424,141
Granted
Mar 22, 2011
Kind
B2
Abstract

An article of clothing is provided for selectively destroying dividing cells in living tissue formed of dividing cells and non-dividing cells. The dividing cells contain polarizable intracellular members and during late anaphase or telophase, the dividing cells are connected to one another by a cleavage furrow. The article of clothing includes insulated electrodes to be coupled to a generator for subjecting the living tissue to electric field conditions sufficient to cause movement of the polarizable intracellular members toward the cleavage furrow in response to a non-homogeneous electric field being induced in the dividing cells. The non-homogeneous electric field produces an increased density electric field in the region of the cleavage furrow. The movement of the polarizable intracellular intracellular members towards the cleavage furrow causes the breakdown thereof which adversely impacts the multiplication of the dividing cells.

Claims (23)

1. An apparatus for selectively destroying dividing cells in a target area of living tissue, the dividing cells having members with strong dipole moments, the apparatus comprising:

an article of clothing constructed to be worn over the target area;

a first insulated electrode having a first conductor and a first dielectric coating, wherein the first insulated electrode is affixed to the article of clothing so that when the article of clothing is worn by a person, the first dielectric coating is positioned between the first conductor and the person's body and is held against the person's body;

a second insulated electrode having a second conductor and a second dielectric coating, wherein the second insulated electrode is affixed to the article of clothing so that when the article of clothing is worn by the person, the second dielectric coating is positioned between the second conductor and the person's body and is held against the person's body; and

an electric potential source configured to impose an alternating electric potential across the first and second conductors, wherein the alternating electric potential and the insulated electrodes are configured to operate together to impose, in the target area, an electric field with frequency and amplitude characteristics such that application of the electric field to the dividing cells in late anaphase or telophase gives rise to a non-homogenous electric field within the dividing cells that causes the members with strong dipole moments within the dividing cells to move in a manner that increases the likelihood that the dividing cells will structurally break apart.

2. The apparatus of claim 1 , wherein the non-homogenous field causes the members with strong dipole moments to move towards a region of a cleavage furrow of the dividing cells.

3. The apparatus of claim 1 , wherein each insulated electrode includes a dielectric layer adjacent the conductor and for placement against the living tissue.

4. The apparatus of claim 3 , wherein the dielectric layer is formed of a material having a high dielectric constant and is selected from the group consisting of lithium nibate (LiNbO3); yttrium iron garnet (YIG); barium titanate (BaTiO3); potassium tantalate (kTaO3); and lithium tantalate (LiTaO3).

5. The apparatus of claim 3 wherein the article of clothing is selected from the group consisting of: a hat, a bra, a neck collar, and an undergarment.

6. The apparatus of claim 3 wherein the frequency of the imposed electric field is between 100 kHz and 300 kHz.

7. The apparatus of claim 3 wherein the intensity of the imposed electric field is between 0.1 V/cm and 10 V/cm.

8. The apparatus of claim 1 wherein the frequency of the imposed electric field is between 100 kHz and 300 kHz and the intensity of the imposed electric field is between 0.1 V/cm and 10 V/cm.

9. A method for selectively destroying dividing cells in a target area of living tissue, the dividing cells having members with strong dipole moments, the method comprising:

holding a first insulated electrode having a first conductor and a first dielectric coating against a person's body using an article of clothing, with the first dielectric coating positioned between the first conductor and the person's body;

holding a second insulated electrode having a second conductor and a second dielectric coating against a person's body using the article of clothing, with the second dielectric coating positioned between the second conductor and the person's body; and

imposing an alternating electric potential across the first and second conductors, wherein the alternating electric potential and the insulated electrodes are configured to operate together to impose, in the target area, an electric field with frequency and amplitude characteristics such that application of the electric field to the dividing cells in late anaphase or telophase gives rise to a non-homogenous electric field within the dividing cells that causes the members with strong dipole moments within the dividing cells to move in a manner that increases the likelihood that the dividing cells will structurally break apart.

10. The method of claim 9 , wherein the non-homogenous field causes the members with strong dipole moments to move towards a region of a cleavage furrow of the dividing cells.

11. The method of claim 9 , wherein each insulated electrode includes a dielectric layer adjacent the conductor and for placement against the living tissue.

12. The method of claim 11 , wherein the dielectric layer is formed of a material having a high dielectric constant and is selected from the group consisting of lithium nibate (LiNbO3); yttrium iron garnet (YIG); barium titanate (BaTiO3); potassium tantalate (kTaO3); and lithium tantalate (LiTaO3).

13. The method of claim 11 , wherein the article of clothing is selected from the group consisting of: a hat, a bra, a neck collar, and an undergarment.

14. The apparatus of claim 11 , wherein the frequency of the imposed electric field is between 100 kHz and 300 kHz.

15. The method of claim 11 , wherein the intensity of the imposed electric field is between 0.1 V/cm and 10 V/cm.

16. The method of claim 9 , wherein the frequency of the imposed electric field is between 100 kHz and 300 kHz and the intensity of the imposed electric field is between 0.1 V/cm and 10 V/cm.

Assignments (18)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034548/0231 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →
CHANGE OF NAME Recorded May 19, 2011
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 026311/0210 →